Commissioner Robert Califf said the federal agency that he’s known for years “is finished” after mass layoffs began Tuesday ...

The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to ...

FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an ...

Most economic analyses say average US families would have to absorb the cost of his tariffs in the form of higher prices and ...

After Roberto Gonzalez’s school visit, eighth-grade Miami students will discuss water fluoridation at the April 1 meeting.

The Coris FDA assent isn’t the first rodeo for Nanosonics, given its Trophon device has been commercialised since 2009. What next?

The complete response letter, issued by the FDA, does not identify what deficiencies regulators found in ...

The Senate voted Tuesday to confirm the heads of two major federal health agencies. Jay Bhattacharya, MD, PhD, will become ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual Meeting TORONTO and HOUSTON, (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, ...

Fox News contributor Dr. Marty Makary was officially confirmed to lead the FDA in Trump's second administration after a vote on Tuesday night.

Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.